Real-time enrollment status for this recurrent b acute lymphoblastic leukemia clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 8:15 AM UTC
| NCT Number | NCT07133997 |
| Recruiting Status | Recruiting |
| Condition | Recurrent B Acute Lymphoblastic Leukemia |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 1 sites in the US |
| Sponsor | City of Hope Medical Center |
| Last Updated on CT.gov | July 14, 2026 (3 days ago) |
As of July 17, 2026: Clinical trial NCT07133997 is currently recruiting participants. This phase1 study for recurrent b acute lymphoblastic leukemia is actively seeking new participants at 1 location across the United States. The study is sponsored by City of Hope Medical Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07133997 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07133997 was last updated 3 days ago (July 14, 2026). HelloStudys verifies this status automatically.